NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market Tuesday that its first-quarter revenues fell 4 percent year over year due to a software problem that resulted in reduced sample processing capacity at its New Haven, Conn., lab testing facility.

The Omaha, Neb.-based firm had total revenues of $7.2 million for the three months ended March 31, compared to $7.5 million for the first quarter of 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.